Cooley advised Landos Biopharma, a clinical-stage biopharmaceutical company focused on the development of first-in-class, oral therapeutics for patients with autoimmune diseases, on its definitive agreement under which it will be acquired by AbbVie.
Key deals, decisions + trends
Close